Advertisement

Mexican President Says He Will Get Russian Vaccine If Effective

Channels Television  
Updated August 17, 2020
This handout picture taken on August 6, 2020 and provided by the Russian Direct Investment Fund shows the vaccine against the coronavirus disease, developed by the Gamaleya Research Institute of Epidemiology and Microbiology. Handout / Russian Direct Investment Fund / AFP
This handout picture taken on August 6, 2020 and provided by the Russian Direct Investment Fund shows the vaccine against the coronavirus disease, developed by the Gamaleya Research Institute of Epidemiology and Microbiology. Handout / Russian Direct Investment Fund / AFP

 

Mexican President Andres Manuel Lopez Obrador said Monday that he would be among the first to receive a Russian coronavirus vaccine if it is shown to be effective.

Russia’s announcement last week that it was the first in the world to approve a coronavirus vaccine was met with caution from Western scientists who said it still needed to be proved safe and effective.

“I would be the first to get vaccinated because it matters a lot to me, but we have to … ensure that it’s something effective and that it’s available to everyone,” Lopez Obrador said at his daily news conference.

The Mexican leader added that he would personally reach out to Russia or China if they are first to develop an effective vaccine.

“In this important matter, there should be no ideologies… health comes first,” he said.

 

A health worker is reflected on a mirror while preparing to the COVID-19 zone of a hospital in Atizapan, Mexico, on May 22, 2020, amid the new coronavirus pandemic. PEDRO PARDO / AFP
File photo: A health worker is reflected in a mirror while preparing to the COVID-19 zone of a hospital in Atizapan, Mexico, on May 22, 2020, amid the new coronavirus pandemic. PEDRO PARDO / AFP

The Latin American country has recorded more than 56,000 coronavirus deaths — the world’s third-highest toll — and over half a million infections.

Mexico announced a deal last week with British-Swedish pharmaceuticals giant AstraZeneca to manufacture its vaccine now under development if clinical trials show it to be effective.

AFP